» Articles » PMID: 27430889

Regulation of Lysosomal Ion Homeostasis by Channels and Transporters

Overview
Specialties Biology
Science
Date 2016 Jul 20
PMID 27430889
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Lysosomes are the major organelles that carry out degradation functions. They integrate and digest materials compartmentalized by endocytosis, phagocytosis or autophagy. In addition to more than 60 hydrolases residing in the lysosomes, there are also ion channels and transporters that mediate the flux or transport of H(+), Ca(2+), Na(+), K(+), and Cl(-) across the lysosomal membranes. Defects in ionic exchange can lead to abnormal lysosome morphology, defective vesicle trafficking, impaired autophagy, and diseases such as neurodegeneration and lysosomal storage disorders. The latter are characterized by incomplete lysosomal digestion and accumulation of toxic materials inside enlarged intracellular vacuoles. In addition to degradation, recent studies have revealed the roles of lysosomes in metabolic pathways through kinases such as mechanistic target of rapamycin (mTOR) and transcriptional regulation through calcium signaling molecules such as transcription factor EB (TFEB) and calcineurin. Owing to the development of new approaches including genetically encoded fluorescence probes and whole endolysosomal patch clamp recording techniques, studies on lysosomal ion channels have made remarkable progress in recent years. In this review, we will focus on the current knowledge of lysosome-resident ion channels and transporters, discuss their roles in maintaining lysosomal function, and evaluate how their dysfunction can result in disease.

Citing Articles

Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation.

He L, Liu Y, Jiang J, Wang D, Li Y, Zeng S Acta Pharmacol Sin. 2025; .

PMID: 40016522 DOI: 10.1038/s41401-025-01507-9.


Lysosomal physiology and pancreatic lysosomal stress in diabetes mellitus.

Hao M, Sebag S, Qian Q, Yang L eGastroenterology. 2024; 2(3).

PMID: 39512752 PMC: 11542681. DOI: 10.1136/egastro-2024-100096.


Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L Signal Transduct Target Ther. 2024; 9(1):211.

PMID: 39174535 PMC: 11344989. DOI: 10.1038/s41392-024-01911-3.


Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases.

Nixon R, Rubinsztein D Nat Rev Mol Cell Biol. 2024; 25(11):926-946.

PMID: 39107446 DOI: 10.1038/s41580-024-00757-5.


Multisystem disorder associated with a pathogenic variant in CLCN7 in the absence of osteopetrosis.

Lee C, Chang Y, Lin H, Lee H, Yeh T, Fang L Mol Genet Genomic Med. 2024; 12(7):e2494.

PMID: 39056574 PMC: 11273547. DOI: 10.1002/mgg3.2494.


References
1.
Melchionda M, Pittman J, Mayor R, Patel S . Ca2+/H+ exchange by acidic organelles regulates cell migration in vivo. J Cell Biol. 2016; 212(7):803-13. PMC: 4810305. DOI: 10.1083/jcb.201510019. View

2.
Kim H, Li Q, Tjon-Kon-Sang S, So I, Kiselyov K, Soyombo A . A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype. EMBO J. 2008; 27(8):1197-205. PMC: 2367400. DOI: 10.1038/emboj.2008.56. View

3.
Wilson P, Morris C, Anson D, Occhiodoro T, Bielicki J, Clements P . Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A. 1990; 87(21):8531-5. PMC: 54990. DOI: 10.1073/pnas.87.21.8531. View

4.
Samie M, Wang X, Zhang X, Goschka A, Li X, Cheng X . A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev Cell. 2013; 26(5):511-24. PMC: 3794471. DOI: 10.1016/j.devcel.2013.08.003. View

5.
Chapel A, Kieffer-Jaquinod S, Sagne C, Verdon Q, Ivaldi C, Mellal M . An extended proteome map of the lysosomal membrane reveals novel potential transporters. Mol Cell Proteomics. 2013; 12(6):1572-88. PMC: 3675815. DOI: 10.1074/mcp.M112.021980. View